|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 21, 2017 ) This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Rosacea market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Rosacea market growth. It takes into account aspects such as drivers, restraints, challenges, and opportunities that impact the market and presents statistical and analytical account on it. This research report features a comprehensive discussion about the current scenario to estimate trends and prospects of the Rosacea market soon. The overall market provides detailed dynamic and statistical insights pertaining to the market at both regional and global level.
Get Free Sample Copy of this Report @: http://www.reportbazzar.com/request-sample/?pid=988836&ptitle=Rosacea+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Sample
Healthcare industry: Is it growing or stagnant?
The healthcare industry or health economy is the aggregation or integration of industries within the economic system that provides goods & services to treat the patients with preventive, curative, palliative and rehabilitative care. Healthcare industry has been grabbing attention in the recent past and is expected to continue a similar trend over the forecast period. Growing number of diseases and increasing concern & awareness about health are the factors contributing to the growth of Rosacea industry and in turn healthcare industry and its related industries. Development of newer products coupled with innovation of new technologies, as well as increasing investments in R&D by companies, is further widening the market scope and revenue growth of the total market.
Research Methodology:
Recognizing the rising prevalence of Rosacea market, this research report proves to be a primary source of guidance and detailed data on the market at global scale. The report evaluates the present scenario as well as changing trends in the market to project its outlook and prospects. A holistic report covers exhaustive information obtained from reliable industrial sources and through proven research methodologies. The report goes through both secondary and primary survey. The base year taken for the report is 2015 and 2016, and a forecast is done from 2017 to 2025.The data thus obtained is then combined with relevant tables and graphs to support the information revealed.
Browse full report with Table of Content @: http://www.reportbazzar.com/product/rosacea-pipeline-review-h1-2017/
Product & Application Insights:
Various competent analytical tools have been used to offer a comprehensive assessment of the market. The report comprises of each aspect of the global market for Rosacea. It starts with the basic information and then advances to the market segmentation based on different criteria such as technology, products, application and regions in general. A detailed analysis is also given on the market penetration and future prospects of the overall industry growth. Each product has its specific applications. There is detailed approach provided for each product and application such has which product has the highest penetration and which application is growing at a significant rate. These factors are complemented by diagrams such as bar graph or pie diagram.
Regional Insights:
Major regions, countries, and sub-segments have been analyzed for providing the better understanding of the market scope worldwide. The regions taken into consideration are North America, Europe, Asia Pacific, Middle East & Africa and Central & South America. The report studies the market by evaluating the manufacturers, suppliers, and supply chain or value chain management. Favorable regulations, prevalent policies and cost structures are also analyzed. The regional markets for the Rosacea market are analyzed by evaluating the pricing of products, logistics, demand, and supply, production capacity, as well as the historical performance of the market in the given region.
Competitive Insights:
The report also provides insights on the competitive landscape of the global Rosacea industry with the leading players profiled in the report. Company profiles are purely tentative in nature and we can profile companies according to your interest at free cost. The Rosacea market is highly competitive and regulated. The company overview, trends, tactics, merger & acquisitions, business strategies, financial metrics of the major participants operating in the global Rosacea market have been reviewed in this study.
Ask for Discount @: http://www.reportbazzar.com/discount-form/?pid=988836&ptitle=Rosacea+%26%238211%3B+Pipeline+Review%2C+H1+2017&req=Discount
Some Points Of Table Of Content:
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Rosacea - Overview
Rosacea - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Rosacea - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Rosacea - Companies Involved in Therapeutics Development
Amorepacific Corp
BioPharmX Inc
Cutanea Life Sciences Inc
ELORAC Inc
Foamix Pharmaceuticals Ltd
Hovione FarmaCiencia SA
Promius Pharma LLC
Sol-Gel Technologies Ltd
Rosacea - Drug Profiles
AC-701 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ACUD-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
benzoyl peroxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
carbamide peroxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DFD-29 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DMT-200 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DMT-210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DMT-220 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EP-0003 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FMX-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
itraconazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
minocycline - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
minocycline - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MSB-03 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
omiganan pentahydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PAC-14028 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rosacea - Dormant Projects
Rosacea - Discontinued Products
Rosacea - Product Development Milestones
Featured News & Press Releases
Jan 18, 2017: Dermata Therapeutics Announces Initiation of Treatment in a Phase 2 Acne Rosacea Clinical Study
Sep 28, 2016: Dermata Therapeutics, LLC Announces Positive Top-line Results from their Phase 1 Pharmacokinetic Study of DMT210 in Acne Rosacea Patients
Sep 12, 2016: Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea
Sep 09, 2016: Foamix to Announce Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline Topical Foam for Moderate-to-Severe Papulopustular Rosacea
May 19, 2016: Galderma Laboratories Announces Availability of New Mirvaso (brimonidine) Topical Gel, 0.33% Pump Dispenser for the Treatment of the Persistent Facial Redness of Rosacea
May 16, 2016: Dermata Therapeutics Announces Initiation of Phase 1 Pharmacokinetic Study
May 03, 2016: Foamix Announces Completion of Enrollment in Phase 2 Clinical Trial of Minocycline Foam (FMX103) for Treatment of Papulopustular Rosacea
Oct 20, 2015: Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea
Apr 17, 2014: Treatment for Facial Redness Associated With Rosacea Now Available in the UK
Feb 26, 2014: mirvaso the first and only treatment targeting the facial redness of rosacea approved by the european commission
Jan 29, 2014: Galderma Announces the Publication of Positive Results of the Long-Term Study of Mirvaso Gel for Treatment of Persistent Erythema of Rosacea
Dec 20, 2013: Galderma Receives CHMP Positive Opinion For Mirvaso
Sep 27, 2013: Galderma Announces Availability of Mirvaso (brimonidine) Topical Gel, 0.33%
Aug 26, 2013: Galderma Receives FDA Approval of Mirvaso
Jul 08, 2013: Signum Dermalogix Investigational New Drug Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
About us:
Reportbazzar.com is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors. Our intelligence database comprises of vast arrays of strategically analyzed and high-level market research reports that encompass all major industries worldwide. All the specialized research reports available at Reportbazzar.com are tailor-made to suit your every business need, no matter how diverse or demanding it is.
ReportBazzar
Mary Jane
+1 (212) 389-6363
sales@reportbazzar.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
